Home Subscription Services

The International Journal of Oral & Maxillofacial Implants
OCTE Home Page
About the Editor
Editorial Board
Author Guidelines
Submission Form
Reprints / Articles
Quintessence Publishing: Journals: OCTE


Oral & Craniofacial Tissue Engineering

Edited by Ole T. Jensen, DDS, MS

Official Journal of the Tissue Engineering Society, the Chinese Society of Oral Biomedicine, and the Japanese Society of Regenerative Medicine

ISSN (print) 2158-3722 • ISSN (online) 2158-3706

Oral & Craniofacial Tissue Engineering
Summer 2012
Volume 2 , Issue 2

Share Abstract:

The Effect of Gabapentin-Lactam Hydroxamic Acid Derivatives on Ovine Osteoblast Proliferation and Phenotype: Perspectives for Tissue Engineering Application

Fabian Duttenhoefer, MD/Marc Anton Fuessinger, MD/Sieglinde Ahne, MD/Toshiyuki Oshima, DMD/Ralf Gutwald, MD, DDS/Rainer Schmelzeisen, MD, DDS/Sebastian Sauerbier, MD, DDS

Pages: 129136

Purpose: Modern bone tissue engineering associated with mesenchymal stem cells (MSCs) provides promising treatment alternatives for the loss of bone, one of the foremost challenges in oral and craniofacial surgery today. The effect of gabapentin-lactam (GBP-L) and its analogs on osteogenic differentiated MSCs has not yet been deciphered. Consequently, this study investigates the effect of novel trans-8-tertbutylgabapentin-lactam (trans-8-TB-GBP-L) hydroxamic acid derivatives on metabolism, proliferation, and physiologic mineralization characteristics of ovine osteoblast cells. Materials and Methods: Osteoblasts were extracted and prepared from sheep femoral heads and cultured in medium enriched with hydroxamic acid derivatives of trans-8-TB-GBP-L. The cell proliferation rate, cell metabolism, cell viability, and basic osteoblastic function were assessed. Results: After 3 and 5 days of incubation, no significant increase in DNA content was detected in any of 12 test groups versus the control group. However, after 8 days of incubation, a significant increase of DNA contents in the test groups containing nanomolar concentrations of trans-8-TB-GBP-L hydroxamic acid derivatives was found. No significant aberration in metabolic activity was detected when any of the test substances were applied. ALP displayed similar activity rates among the test groups and the control at all time points. Calcification of osteoblastic cells occurred solely when nanomolar concentrations were used. Conclusion: Trans-8-TB-GBP-L hydroxamic acid derivatives do not interfere with physiologic function and phenotype of ovine osteoblasts. However, when applied at nanomolar concentrations, the assessed GBP-L derivatives significantly increased the cell proliferation rate after 8 days of incubation, indicating a dose-response curve with the maximum peak at nanomolar concentration and a retarded drug response between 5 and 8 days. ORAL CRANIOFAC TISSUE ENG 2012;2:129136

Key words: gabapentin-lactam analogs, osteoblast proliferation, tissue engineering, trans-8-tertbutylgabapentin-lactam hydroxamic acid derivatives

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.
  © 2017 Quintessence Publishing Co Inc

Home | Subscription Services | Books | Journals | Multimedia | Events | Blog
Terms of Use | Privacy Policy | About Us | Contact Us | Advertising | Help | Sitemap | Catalog